2024-11-06 REL RCSB RCSB RCSB 2018-01-16 2018-02-07 2018-05-02 2024-11-06 National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) R01GM120553 United States National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) HHSN272201700059C United States An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus Snijder J Ortego MS Epstein-Barr virus, neutralizing antibodies, gH/gL, glycoproteins, Structural Genomics, Seattle Structural Genomics Center for Infectious Disease, SSGCID, VIRAL PROTEIN Snijder J Ortego MS Weidle C Stuart AB Gray MD McElrath MJ Pancera M Veesler D McGuire AT An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus. Immunity US 48 799 811.e9 2018 29669253 doi:10.1016/j.immuni.2018.03.026 1097-4180 2048 IUNIEH EMD-7345 other EM volume 6c5v FULLOVERLAP Epstein-Barr virus glycoproteins H,L,42 in complex with the human antibody Fab fragment AMMO1. Epstein-Barr virus glycoproteins H,L,42 in complex with the human antibody Fab fragment AMMO1. 0 1 2 3 4 5 Epstein-Barr virus 1 1 2 3 Human herpesvirus 4 Human 1 4 5 Homo sapiens Envelope glycoprotein H Human herpesvirus 4 GD1 0.077091547 1 Homo sapiens LEVO MDAMKRGLCCVLLLCGAVFVSPSASSLSEVKLHLDIEGHASHYTIPWTELMAKVPGLSPEALWREANVTEDLASMLNRYK LIYKTSGTLGIALAEPVDIPAVSEGSMQVDASKVHPGVISGLNSPACMLSAPLEKQLFYYIGTMLPNTRPHSYVFYQLRC HLSYVALSINGDKFQYTGAMTSKFLMGTYKRVTEKGDEHVLSLVFGKTKDLPDLRGPFSYPSLTSAQSGDYSLVIVTTFV HYANFHNYFVPNLKDMFSRAVTMTAASYARYVLQKLVLLEMKGGCREPELDTETLTTMFEVSVAFFKVGHAVGETGNGCV DLRWLAKSFFELTVLKDIIGICYGATVKGMQSYGLERLAAMLMATVKMEELGHLTTEKQEYALRLATVGYPKAGVYSGLI GGATSVLLSAYNRHPLFQPLHTVMRETLFIGSHVVLRELRLNVTTQGPNLALYQLLSTALCSALEIGEVLRGLALGTESG LFSPCYLSLRFDLTRDKLLSMAPQEATLDQAAVSYAVDGFLGRLSLEREDRDAWHLPAYKCVDRLDKVLMIIPLINVTFI ISSDREVRGSALYEASTTYLSSSLFLSPVIMNKCSQGAVAGEPRQIPKIQNFTRTQKSCIFCGFALLSYDEKEGLETTTY ITSQEVQNSILSSNYFDFDNLHVHYLLLTTNGTVMEIAGLYEERAHGSGSGHHHHHH K9US75 Envelope glycoprotein L Human herpesvirus 4 AG876 0.015145394999999999 1 Homo sapiens LEVO MDAMKRGLCCVLLLCGAVFVSPSASWAYPCCHVTQLRAQHLLALENISDIYLVSNQTCDGFSLASLNSPKNGSNQLVISR CANGLNVVSFFISILKRSSSALTGHLRELLTTLETLYGSFSVEDLFGANLNRYAWHRGG Q1HVF6 Glycoprotein 42 Human herpesvirus 4 GD1 0.025356859 1 Homo sapiens LEVO MDAMKRGLCCVLLLCGAVFVSPSASGGGRVAAAAITWVPKPNVEVWPVDPPPPVNFNKTAEQEYGDKEVKLPHWTPTLHT FQVPQNYTKANCTYCNTREYTFSYKGCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNAIESLWVGVY RVGEGNWTSLDGGTFKVYQIFGSHCTYVSKFSTVPVSHHECSFLKPCLCVSQRSNSGSGSGHHHHHH P0C6Z5 Antibody Fab AMMO1 heavy chain Homo sapiens 0.023982885 1 Homo sapiens LEVO (PCA)VQLVQSGADVKKPGASVKVSCKASGYTFIHFGISWVRQAPGQGLEWMGWIDTNNGNTNYAQSLQGRVTMTTDTST GTAYMELRSLSTDDTAVYFCARALEMGHRSGFPFDYWGQGVLVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYF PEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC Antibody Fab AMMO1 light chain Homo sapiens 0.023095513999999998 1 Homo sapiens LEVO SYELTQPPSVSVAPGQRATITCGGHNIGAKNVHWYQQKPGQAPVLVIQYDSDRPSGIPERFSGSNSGSTATLTISRVEAG DEADYYCQVWDSGRGHPLYVFGGGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVK AGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 8 NAG singleParticle particle 7.5 ETHANE FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 GATAN K2 SUMMIT (4k x 4k) COUNTING 65.0 1 C1 4.8 FSC 0.143 CUT-OFF 72000 PROJECTION MATCHING PROJECTION MATCHING emd_7344.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 224 224 224 0 0 0 224 224 224 304.64 304.64 304.64 90.0 90.0 90.0 X Y Z -0.15324071 0.30906358 0.00055957725 0.007286191 1.36 1.36 1.36 0.08 AUTHOR An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus